Skip to content
  • Log In
  • EN
Old Pharma Logo HR - International
  • Why O.L.D.?
  • About Us
  • Our Services
  • Products
  • Blog
    • Achievement
    • Active Pharmaceutical Ingredients
    • Pharmamarket
    • Events
  • Contact
  • Toggle website search
MENU CHIUDI
Read more about the article Aflibercept: the innovation that has revolutionized retinal disease therapy

Aflibercept: the innovation that has revolutionized retinal disease therapy

In recent years, the treatment of retinal diseases has experienced remarkable progress. Conditions that once led to inevitable visual deterioration can now be effectively and durably controlled. Among the key…

Continue ReadingAflibercept: the innovation that has revolutionized retinal disease therapy
oldpharma logo
  • Achievement (3)
  • Active Pharmaceutical Ingredients (7)
  • Events (4)
  • Pharmamarket (4)

Recent Articles

  • Uno in Più Cover
    A Christmas of shared commitment: OLD PHARMA supporting the association Uno in Più01/12/2025
    This Christmas, OLD PHARMA has chosen to support a project that reflects the values it fully embraces: inclusion, respect for… Read more: A Christmas of shared commitment: OLD PHARMA supporting the association Uno in Più
  • GDP Old Pharma
    GDP Certification. An official recognition of OLD PHARMA’s consolidated practices in pharmaceutical distribution18/11/2025
    OLD PHARMA is pleased to announce the achievement of the GDP Good Distribution Practices certification, a result that confirms full… Read more: GDP Certification. An official recognition of OLD PHARMA’s consolidated practices in pharmaceutical distribution
  • Aflibercept: the innovation that has revolutionized retinal disease therapy27/10/2025
    In recent years, the treatment of retinal diseases has experienced remarkable progress. Conditions that once led to inevitable visual deterioration… Read more: Aflibercept: the innovation that has revolutionized retinal disease therapy
  • Lactulose
    Lactulose: a cornerstone therapy with growing market perspectives30/09/2025
    A well-established therapeutic profile Lactulose is a synthetic disaccharide derived from lactose and has been widely used in clinical practice… Read more: Lactulose: a cornerstone therapy with growing market perspectives
  • AI Pharmaceutical - Old Pharma
    Artificial Intelligence in the Pharmaceutical Industry: Unlocking Present Value and Shaping the Future28/03/2025
    The pharmaceutical industry is undergoing a radical transformation, and at the heart of this evolution lies Artificial Intelligence (AI) and… Read more: Artificial Intelligence in the Pharmaceutical Industry: Unlocking Present Value and Shaping the Future

Old Pharma International

Perchè O.L.D?

Lavora con Noi

Who We Are

Services

Products

Newsroom

Contact Us

Recent Posts

  • A Christmas of shared commitment: OLD PHARMA supporting the association Uno in Più
    A Christmas of shared commitment: OLD PHARMA supporting the association Uno in Più
    01/12/2025/
    0 Comments
  • GDP Certification. An official recognition of OLD PHARMA’s consolidated practices in pharmaceutical distribution
    GDP Certification. An official recognition of OLD PHARMA’s consolidated practices in pharmaceutical distribution
    18/11/2025/
    0 Comments
  • Aflibercept: the innovation that has revolutionized retinal disease therapy
    Aflibercept: the innovation that has revolutionized retinal disease therapy
    27/10/2025/
    0 Comments

Categories

  • Achievement
  • Active Pharmaceutical Ingredients
  • Events
  • Pharmamarket

Reserved Area

Log in
  • Log In
  • EN
© 2025 OLD PHARMA International S.r.l. - M.F.Quintiliano, 30 20138 Milano (IT)

PIVA 10714760153 - SDI: 7HE8RN5

UFFICI: +39025097500 - MAGAZZINO: +39025097783

marketing@oldpharma.it - oldpharmainternationalsrl@ticertifica.it

Sitemap - Privacy Policy - Cookie Policy - Dichiarazione di Accessibilità

Webdesign sandrinifabio.it

  • Why O.L.D.?
  • About Us
  • Our Services
  • Products
  • Blog
    • Achievement
    • Active Pharmaceutical Ingredients
    • Pharmamarket
    • Events
  • Contact
Type your search

Post Ln Chiusura 2025

Old Pharma Logo HR - International
Cookie Policy oldpharma.it

To provide the best experiences, we use technologies such as cookies to store and/or access information on your device. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or refusing consent may negatively impact certain features and functions.

Functional Always active
Technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferenze
L'archiviazione tecnica o l'accesso sono necessari per lo scopo legittimo di memorizzare le preferenze che non sono richieste dall'abbonato o dall'utente.
Statistics
Technical storage or access that is used exclusively for statistical purposes. Technical storage or access that is used exclusively for statistical purposes.
Marketing
Technical storage or access is necessary to create user profiles for sending advertising, or to track the user on a website or across different websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}